Skip to content
Disclosery

DC Funds, LP

Follow

13F filer, CIK 1869028, MCLEAN, VA

DC Funds, LP reported $2,066,797 across 3 holdings for the quarter ended 2025-03-31, in a 13F-HR filed 2025-05-14.

Filed (acceptance time not in the bulk data set), ingested 13F-HR 0001398344-25-009329

Period
2025-03-31
Reported value
$2.07M
Holdings
3
Top 10 weight
100%
New
0
Sold out
0

Holdings, Q1 2025

Share positions as resolved from 13F-HR 0001398344-25-009329, largest first. % of portfolio is the value over $2,066,797, the sum of the share positions whose value is usable for ratios (method).

SecurityHistorySharesValue% of portfolioChangeLatest eventTimeline
TCRXTSCAN THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 630,000 shares; 2024Q4: 630,000 shares; 2025Q1: 630,000 shares 630,000$869K42.07%0Timeline
BRNSBARINTHUS BIOTHERAPEUTICS PLQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 642,204 shares; 2024Q4: 642,204 shares; 2025Q1: 642,204 shares 642,204$625K30.22%0Timeline
HOWLWEREWOLF THERAPEUTICS INCQuarterly shares; oldest to newest; scale is this security's eight-quarter maximum; 2023Q2: restricted; 2023Q3: restricted; 2023Q4: restricted; 2024Q1: restricted; 2024Q2: restricted; 2024Q3: 589,102 shares; 2024Q4: 589,102 shares; 2025Q1: 589,102 shares 589,102$573K27.71%0Timeline

How Q1 2025 was built

Available 13F filings of this filer for the quarter and their roles: the base report is the latest original or restatement, NEW HOLDINGS amendments filed after it are added (method).

FilingRoleAmendmentFiledAcceptedIngested
13F-HR 0001398344-25-009329 base2025-05-14acceptance time not in the bulk data set